CN114053361A - Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof - Google Patents
Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof Download PDFInfo
- Publication number
- CN114053361A CN114053361A CN202111453887.6A CN202111453887A CN114053361A CN 114053361 A CN114053361 A CN 114053361A CN 202111453887 A CN202111453887 A CN 202111453887A CN 114053361 A CN114053361 A CN 114053361A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- swelling
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 66
- 206010021531 Impetigo Diseases 0.000 title claims abstract description 53
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims description 9
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 31
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 23
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 23
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 23
- 241001116389 Aloe Species 0.000 claims abstract description 22
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 22
- 239000004863 Frankincense Substances 0.000 claims abstract description 20
- 239000009136 dragon's blood Substances 0.000 claims abstract description 20
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 19
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 19
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 19
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims abstract description 19
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims abstract description 19
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 18
- 239000002383 tung oil Substances 0.000 claims abstract description 18
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 14
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 12
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 230000002579 anti-swelling effect Effects 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 7
- 206010030113 Oedema Diseases 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000003501 anti-edematous effect Effects 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 3
- 241000234282 Allium Species 0.000 claims 6
- 230000000694 effects Effects 0.000 abstract description 30
- 244000291564 Allium cepa Species 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 20
- 230000036407 pain Effects 0.000 abstract description 20
- 230000008961 swelling Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 2
- 206010042674 Swelling Diseases 0.000 description 22
- 230000001737 promoting effect Effects 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 9
- 244000173853 Sanguisorba officinalis Species 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- 206010037888 Rash pustular Diseases 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 208000029561 pustule Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003405 preventing effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000581682 Sanguisorba Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000022535 Infectious Skin disease Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application discloses an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo, which comprises the following components in parts by weight: 0.2 to 27 parts of rosin, 0.1 to 16 parts of yellow wax, 0.2 to 15 parts of frankincense, 0.3 to 23 parts of myrrh, 0.4 to 19 parts of dragon's blood, 5 to 36 parts of fistular onion stalk, 4 to 34 parts of tung oil, 1 to 25 parts of garden burnet and 2 to 29 parts of aloe. The application provides a traditional Chinese medicine ointment for diminishing inflammation and removing swelling for treating impetigo herpetifomis, all medicines are mutually matched, so that the wound surface of the impetigo herpetifomis is fast to heal, the traditional Chinese medicine ointment has the effects of clearing heat and activating blood, removing blood stasis and swelling, diminishing inflammation and resisting bacteria, local pain can be improved, blood circulation is promoted, the antibacterial capability of local tissues is enhanced, the cure rate of treating the impetigo herpetifomis is high, the ointment is convenient to use, free of side effects and good in safety.
Description
Technical Field
The application relates to the field of anti-inflammation and detumescence ointment, in particular to an anti-inflammation and detumescence traditional Chinese medicine ointment for treating impetigo and a preparation method thereof.
Background
Impetigo is also called infectious pyoderma, commonly called as 'impetigo', is the most common pyococcus infectious skin disease, and is the most common type of impetigo vulgaris, and the clinical characteristics of the impetigo are papules, blisters or pustules, which are easy to break and then form pyoscabs, are in contact infection and spread rapidly, can be epidemic in children, and the impetigo vulgaris is also called as contact infectious impetigo, and is often staphylococcus aureus infection or mixed infection with hemolytic streptococcus.
The most obvious symptoms of the impetigo herpetifomis patients are pruritus and pain, and are accompanied by symptoms of fever, poor sleep and the like, if the patients are not treated in time, the skin infection area can be enlarged, the normal life of the patients is influenced, the existing treatment is mostly to inject anti-inflammation and pain-relieving medicines to relieve the symptoms of the impetigo herpetifomis patients, so the recurrence rate is high, the risk of generating medicine dependence exists, and the requirements of the patients are difficult to meet.
Therefore, how to improve the treatment effect of impetigo has become a problem to be solved by those skilled in the art.
Disclosure of Invention
In order to solve the technical problems, the application provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo, which can improve the treatment effect of the impetigo.
The technical scheme provided by the application is as follows:
the application provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo, which comprises the following components in parts by weight: 0.2 to 27 parts of rosin, 0.1 to 16 parts of yellow wax, 0.2 to 15 parts of frankincense, 0.3 to 23 parts of myrrh, 0.4 to 19 parts of dragon's blood, 5 to 36 parts of fistular onion stalk, 4 to 34 parts of tung oil, 1 to 25 parts of garden burnet and 2 to 29 parts of aloe.
Further, in a preferred mode of the invention, the composition comprises the following components in parts by weight: 0.5 to 21 parts of rosin, 0.1 to 13 parts of yellow wax, 0.2 to 12 parts of frankincense, 0.3 to 19 parts of myrrh, 0.4 to 16 parts of dragon's blood, 7 to 28 parts of fistular onion stalk, 5 to 31 parts of tung oil, 1 to 20 parts of garden burnet and 2 to 24 parts of aloe.
Further, in a preferred mode of the invention, the composition comprises the following components in parts by weight: 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh, 0.4-12 parts of dragon's blood, 8-23 parts of fistular onion stalk, 7-25 parts of tung oil, 1-16 parts of garden burnet and 3-20 parts of aloe.
In the invention, the traditional Chinese medicine for treating impetigo has the following effects:
colophonium has effects in dispelling pathogenic wind, removing dampness, expelling pus, removing toxic substance, promoting granulation, and relieving pain, and can be used for treating surgical swelling and toxic substance, such as tinea, alopecia areata, arthralgia caused by rheumatism and rheumatoid, trauma, leukorrhagia of women, and thromboangiitis obliterans.
The yellow wax has the effects of detoxifying, promoting granulation, stopping bleeding, relieving pain, promoting blood circulation, promoting metabolism and promoting granulation tissue generation at a wound, has a certain function of expanding blood vessels, has a certain function of diminishing inflammation and disinfecting, can be used for treating traumas such as burns, scalds, traumatic injuries, sharp instrument lacerations and the like, can promote wound healing, contains a large amount of active ingredients and acidic substances, and has the functions of clearing heat and detoxifying.
The frankincense has the effects of regulating qi, activating blood circulation, relieving pain and removing blood stasis, is pungent and bitter in taste, warm in nature, enters heart, liver and spleen diameters, can treat blood stasis caused by qi stagnation, can also treat pain of heart and abdomen, such as angina pectoris, chest distress and other diseases, has the effect of activating blood circulation, can be used for treating furuncle, sore and pyogenic infections, can be used for treating local swelling and pain caused by traumatic injury, and has the effect of removing blood stasis on dysmenorrheal and postpartum blood stasis and pain.
The property and flavor of myrrh are pungent, bitter and flat, and enter heart channel, liver channel and spleen channel, the efficacy and function of myrrh are stasis dissipating and pain relieving, swelling subsiding and tissue regeneration promoting, and are used for treating chest stuffiness and pains, epigastric pain, dysmenorrheal amenorrhea, postpartum stasis, abdominal mass and pain, rheumatic arthralgia, traumatic injury, carbuncle swelling and sore and ulcer, etc., the property of myrrh is bitter and pungent-purgation powder, the property of the drug is relatively mild, the function of the drug is to disperse qi stagnation, activate blood and remove stasis, and relieve pain, besides, the myrrh is also good at activating blood and removing stasis, and swelling subsiding and relieving pain, and can promote granulation, heal wound, and is a common medicine for treating traumatic injury, swelling pain, and sore pain of surgery.
The dragon's blood has the effects of stopping bleeding, healing sore and eliminating carbuncle swelling, can be used for external use and also can be used for oral administration, has the effects of stopping bleeding, healing sore and eliminating carbuncle swelling for external use, has the effects of promoting blood circulation and stopping bleeding for oral administration, has the effects of healing sore and promoting granulation, and can promote wound healing by external use.
The scallion stalk has the effects of inducing sweat, relieving exterior syndrome, dispersing wind cold, dredging up-down yang qi, preventing miscarriage and stopping bleeding, can also be used for treating diseases such as unsmooth lactation, mastitis and the like of women after delivery, and treating stomachache, hyperacidity and dyspepsia caused by cold and cool, and in addition, the scallion stalk can be used for treating furuncle and pyogenic infections, contains volatile oil and components of scallion-garlic-capsaicin, has a strong bactericidal effect and has a certain effect on preventing cold.
Tung oil has the effects of eliminating lumps, relieving ulcers and treating inflammation, is commonly used for relieving swelling and pain, eliminating ulcers and eliminating inflammation, can accelerate healing of ulcer surfaces and relieve pain, and has remarkable treatment effect on dermatophytosis and skin inflammation.
Sanguisorba has the effects of cooling blood, stopping bleeding, clearing heat and removing toxicity, can be used for clearing heat toxin of a human body, treating bleeding diseases such as hematemesis, hematuria and hemafecia, and can be used for treating red and white leukorrhea, eczema, dysentery, even burn, scald, furuncle, swelling and pain and other diseases. Clinically, sanguisorba can be used for treating purpura and hematochezia.
Aloe has effects of killing bacteria, resisting inflammation, removing toxic substances, promoting wound healing, invigorating stomach, promoting excretion, relieving pain, tranquilizing, preventing insects, preventing corrosion, caring skin, tonifying heart, promoting blood circulation, improving body constitution, and resisting aging, and can promote healing of ulcer surface, and can be used for treating gastritis and gastric ulcer.
Compared with the prior art, the anti-inflammation and detumescence traditional Chinese medicine ointment for treating impetigo provided by the invention comprises the following components in parts by weight: compared with the prior art, the anti-inflammation and detumescence traditional Chinese medicine ointment for treating impetigo disclosed by the invention has the advantages that the traditional Chinese medicine ointment is matched with the medicines, so that the wound surface of the impetigo is quickly healed, the traditional Chinese medicine ointment has the effects of clearing heat, activating blood, reducing swelling, removing blood stasis, diminishing inflammation and resisting bacteria, local pain can be improved, blood circulation is promoted, the antibacterial capability of local tissues is enhanced, the cure rate for treating the impetigo is high, the ointment is convenient to use, free of side effect and good in safety.
The application also provides a preparation method of the anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo, which comprises the following steps:
s1, washing and airing 8-23 parts of fistular onion stalk, slicing, juicing, and filtering to obtain fistular onion stalk juice;
s2, taking 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh and 0.4-12 parts of dragon' S blood, cleaning impurities, drying, grinding, and sieving with a 300-mesh sieve to obtain mixed medicinal powder;
s3, peeling 3-20 parts of aloe, putting the aloe into a container without water and oil, adding the mixed medicinal powder obtained in the step S2, and stirring to be thick to obtain an ointment;
s4, placing 7-25 parts of tung oil into a clean earthen pot, adding the fistular onion stalk juice obtained in the step S1 according to the mass ratio of 1:1.2-1.7, heating with soft fire for 0.3-0.5h, and cooling to obtain a mixed solution;
s5, mixing the mixed liquid in the step S4 and the ointment in the step S3 according to the mass ratio of 2:1.1-1.6, uniformly stirring, and disinfecting under an ultraviolet lamp to obtain the anti-inflammation and edema-removing traditional Chinese medicine ointment for treating the impetigo.
Further, in a preferred embodiment of the present invention, the filtering in step S1 is specifically: filtering with 400 mesh filter screen for 3 times.
Further, in a preferred mode of the present invention, the drying temperature in the step S2 is 75 to 100 ℃.
Further, in a preferred mode of the present invention, the stirring speed in the step S3 is 200-350 r/min.
Further, in a preferred embodiment of the present invention, the mixed solution and the ointment in step S5 are mixed in a mass ratio of 2:1.2 to 1.5.
Compared with the prior art, the technical scheme provided by the invention has the advantages that the preparation method of the anti-inflammation and detumescence traditional Chinese medicine ointment for treating impetigo is simple and convenient to operate, the raw materials are wide and easy to obtain, and the preparation cost is low.
Drawings
In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present application, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
Fig. 1 is a schematic flow chart of a preparation method of an anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo provided by an embodiment of the invention.
Detailed Description
In order to make those skilled in the art better understand the technical solutions in the present application, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the drawings in the embodiments of the present application, and it is obvious that the described embodiments are only a part of the embodiments of the present application, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
It will be understood that when an element is referred to as being "fixed" or "disposed" on another element, it can be directly on the other element or be indirectly disposed on the other element; when an element is referred to as being "connected to" another element, it can be directly connected to the other element or be indirectly connected to the other element.
It will be understood that the terms "length," "width," "upper," "lower," "front," "rear," "first," "second," "vertical," "horizontal," "top," "bottom," "inner," "outer," and the like, as used herein, refer to an orientation or positional relationship indicated in the drawings that is solely for the purpose of facilitating the description and simplifying the description, and do not indicate or imply that the referenced device or element must have a particular orientation, be constructed and operated in a particular orientation, and thus should not be considered as limiting the present application.
Furthermore, the terms "first", "second" and "first" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of the present application, "plurality" or "a plurality" means two or more unless specifically limited otherwise.
It should be understood that the structures, ratios, sizes, and the like shown in the drawings are only for illustrative purposes and are not intended to limit the scope of the present disclosure, so that those skilled in the art can understand and read the present disclosure, and the present disclosure is not limited to the conditions and conditions that can be implemented in the present disclosure.
The application provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo, which comprises the following components in parts by weight: 0.2 to 27 parts of rosin, 0.1 to 16 parts of yellow wax, 0.2 to 15 parts of frankincense, 0.3 to 23 parts of myrrh, 0.4 to 19 parts of dragon's blood, 5 to 36 parts of fistular onion stalk, 4 to 34 parts of tung oil, 1 to 25 parts of garden burnet and 2 to 29 parts of aloe.
Specifically, in the embodiment of the invention, the paint comprises the following components in parts by weight: 0.5 to 21 parts of rosin, 0.1 to 13 parts of yellow wax, 0.2 to 12 parts of frankincense, 0.3 to 19 parts of myrrh, 0.4 to 16 parts of dragon's blood, 7 to 28 parts of fistular onion stalk, 5 to 31 parts of tung oil, 1 to 20 parts of garden burnet and 2 to 24 parts of aloe.
Specifically, in the embodiment of the invention, the paint comprises the following components in parts by weight: 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh, 0.4-12 parts of dragon's blood, 8-23 parts of fistular onion stalk, 7-25 parts of tung oil, 1-16 parts of garden burnet and 3-20 parts of aloe.
As shown in fig. 1, the present application further provides a method for preparing an anti-inflammatory and anti-swelling Chinese medicinal ointment for treating impetigo, which comprises the following steps:
s1, washing and airing 8-23 parts of fistular onion stalk, slicing, juicing, and filtering to obtain fistular onion stalk juice;
s2, taking 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh and 0.4-12 parts of dragon' S blood, cleaning impurities, drying, grinding, and sieving with a 300-mesh sieve to obtain mixed medicinal powder;
s3, peeling 3-20 parts of aloe, putting the aloe into a container without water and oil, adding the mixed medicinal powder obtained in the step S2, and stirring to be thick to obtain an ointment;
s4, placing 7-25 parts of tung oil into a clean earthen pot, adding the fistular onion stalk juice obtained in the step S1 according to the mass ratio of 1:1.2-1.7, heating with soft fire for 0.3-0.5h, and cooling to obtain a mixed solution;
s5, mixing the mixed liquid in the step S4 and the ointment in the step S3 according to the mass ratio of 2:1.1-1.6, uniformly stirring, and disinfecting under an ultraviolet lamp to obtain the anti-inflammation and edema-removing traditional Chinese medicine ointment for treating the impetigo.
Specifically, in the embodiment of the present invention, the filtering in step S1 specifically is: filtering with 400 mesh filter screen for 3 times.
It should be added that, in the embodiment of the present invention, 13 parts of fistular onion stalk is used in the step S1.
Specifically, in the embodiment of the present invention, the drying temperature in step S2 is 75 to 100 ℃.
It should be added that, in the embodiment of the present invention, the rosin in the step S2 is 4 parts.
It should be added that, in the embodiment of the present invention, the yellow wax in the step S2 is 1 part.
It should be added that, in the present embodiment, the amount of the olibanum in the step S2 is 1 part.
It should be added that, in the embodiment of the present invention, the amount of the myrrh in the step S2 is 1 part.
It should be added that, in the embodiment of the present invention, the amount of the dragon' S blood in the step S2 is 1 part.
Specifically, in the embodiment of the present invention, the stirring speed in the step S3 is 200-350 r/min.
It should be noted that, in the embodiment of the present invention, the heating temperature in the step S4 is 100-120 ℃.
More specifically, the cooling in step S4 is specifically: cooling to room temperature under sealed condition.
It should be added that, in the embodiment of the present invention, the mixing mass ratio of the tung oil to the fistular onion stalk juice in the step S4 is 1: 1.5.
Specifically, in the embodiment of the present invention, the mixed liquid and the ointment in step S5 are mixed according to a mass ratio of 2: 1.2-1.5.
More specifically, the mixed liquid and the ointment in the step S5 are mixed according to a mass ratio of 2: 1.3.
It should be noted that, in the embodiment of the present invention, the stirring speed in the step S5 is 350r/min and the stirring time is 10-18 min.
It should be added that, in the embodiment of the present invention, the anti-inflammatory and edema-removing traditional Chinese medicine ointment for treating impetigo comprises the following components by weight: 4 parts of rosin, 1 part of yellow wax, 1 part of frankincense, 1 part of myrrh, 1 part of dragon's blood, 13 parts of fistular onion stalk, 10 parts of tung oil, 3 parts of garden burnet root and 5 parts of aloe.
To better illustrate the therapeutic effect of the anti-inflammatory and anti-edema traditional Chinese medicine ointment for treating impetigo according to the embodiment of the present invention, the preparation of the anti-inflammatory and anti-edema traditional Chinese medicine ointment for treating impetigo is exemplified by the configuration of the components with different weight and specific gravity:
example 1:
the embodiment provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo herpetifomis, which is prepared by cleaning and airing 5 parts of fistular onion stalk, slicing, juicing, filtering to obtain fistular onion stalk juice, 0.2 part of rosin, 0.1 part of yellow wax, 0.2 part of frankincense, 0.3 part of myrrh and 0.4 part of dragon' S blood, cleaning impurities, drying at the temperature of 75-100 ℃, grinding, sieving with a 300-mesh sieve to obtain mixed medicinal powder, peeling 2 parts of aloe, placing in a container without water and oil, adding the mixed medicinal powder in the step S2, stirring at the speed of 200-350r/min to be thick to obtain an ointment, placing 4 parts of tung oil in a clean sand pot, adding the fistular onion stalk juice in the step S1 according to the mass ratio of 1:15, heating the ointment with small fire for 0.3-0.5h, cooling to the room temperature under the sealing condition to obtain a mixed solution, mixing the mixed solution with the ointment in the step S3 according to the mass ratio of 2:13, stirring at the speed of 250-350r/min, stirring for 10-18min, and sterilizing the first ultraviolet lamp .
Example 2:
the embodiment provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo herpetifomis, 13 parts of fistular onion stalk is cleaned and aired, the fistular onion stalk is sliced and juiced, the juice is filtered to obtain fistular onion stalk juice, 4 parts of rosin, 1 part of yellow wax, 1 part of frankincense, 1 part of myrrh and 1 part of dragon blood are dried at the temperature of 75-100 ℃ after impurities are cleaned, the juice is ground and sieved by a 300-mesh sieve to obtain mixed medicinal powder, 5 parts of aloe is peeled and placed in a container without water and oil, the mixed medicinal powder in the step S2 is added, the mixture is stirred to be thick at the speed of 200- .
Example 3:
the embodiment provides an anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo herpetifomis, 23 parts of fistular onion stalk is cleaned and aired, sliced and juiced, filtered to obtain fistular onion stalk juice, 18 parts of rosin, 11 parts of yellow wax, 9 parts of frankincense, 14 parts of myrrh and 12 parts of dragon blood are dried at the temperature of 75-100 ℃ after impurities are cleaned, ground and sieved by a 300-mesh sieve to obtain mixed medicinal powder, 20 parts of aloe is peeled and placed in a container without water and oil, the mixed medicinal powder in the step S2 is added, the mixture is stirred to be thick at the speed of 200- .
Example 4:
the fourth ointment is prepared from proper amount of topical medicine suitable for treating impetigo herpetifomis (such as erythromycin ointment and zinc oxide cream).
60 cases of impetigo patients were selected and randomly divided into four groups, and four groups of patients all met the following diagnostic criteria: the skin lesions are well developed on the face, scalp and limbs, the face is mainly around the mouth, nostrils and auricle, the severe person can develop the whole body, the initial lesions are erythema and blister, the erythema and blister rapidly become pustule, the millet grains are soybean in size, the blister wall has reddish halo around, the skin is plump and tense at first, the skin can be relaxed later, especially when the skin is in a half pot shape, the upper half of the sore is clear liquid, and the lower half is turbid pus liquid, and the skin is in a bag shape and falls down. The erosion face is exposed after the blister is broken, and the dry blister is covered with honey-yellow or gray-yellow scab which can spread to the periphery due to self-propagation and can be fused into a tablet, so that patients feel pruritus and fever, and the body temperature is even as high as 39-40 ℃, and lymph node or lymphangitis can be accompanied.
The information for four groups of patients is as follows:
experiment group one: 7 men and 8 women, age 5-9 years; experiment group two: 7 men and 8 women, age 4-9 years; experiment group three: 8 men and 7 women, age 4-8 years; experiment group one: 7 men and 8 women, age 5-8 years, the general data of the above four groups have no significant difference and are comparable.
Applying the first ointment to the pustule swelling part of a patient in the first experimental group twice in the morning and at night, wherein 2g of the first ointment is taken once, and 3 days are 1 treatment course; applying the second ointment to the pustule swelling part of patients in the second experimental group twice in the morning and at night, wherein 2g of the second ointment is taken once, and 3 days are 1 treatment course; applying the third ointment to the pustule swelling part of patients in experiment group three twice in the morning and at night, wherein 2g of the third ointment is taken once, and 3 days are 1 treatment course; the patients in the fourth experimental group were applied with erythromycin ointment to the pustule swelling area twice in the morning and at night, 2g was taken once, 3 days was taken as 1 treatment course, and four groups of patients were treated after 2 treatment courses, and the statistics of the wound surface area change before and after treatment of four groups of patients in table 1 and the treatment effect comparison table in table 2 are shown.
The therapeutic effect judgment standard is as follows: and (3) healing: crusting and falling off impetigo, and completely repairing local tissues; the effect is shown: crusting impetigo, and reducing sore area; the method has the following advantages: the sore area is reduced, the color is lightened, and the exudate is reduced; and (4) invalidation: no local change or emphasis.
TABLE 1 comparison table of wound surface area changes before and after treatment for four groups of patients
TABLE 2 comparative table of therapeutic effects of four groups of patients
| Group of | n | Recovery rate | Display effect (rate) | Effective (rate) | Ineffectiveness (rate) |
| Experiment set 1 | 15 | 4(26.67％) | 3(20％) | 5(33.33％) | 3(20％) |
| Experiment group two | 15 | 6(40％) | 5(33.33％) | 3(20％) | 1(6.67％) |
| Experiment group III | 15 | 5(33.33％) | 4(26.67％) | 4(26.67％) | 2(13.33％) |
| Experiment group four | 15 | 3(20％) | 4(26.67％) | 4(26.67％) | 4(26.67％) |
Through the observation results of the above 60 patients, 18 cases of treatment recovery, 16 cases of treatment significant effect, 16 cases of treatment effective and 10 cases of treatment ineffective, and the above 60 patients have no adverse reaction during the treatment period and after drug withdrawal, and because of the difference of the body constitution of each patient, it is difficult to ensure the complete consistency of the experimental conditions, so there is a certain error in the above experimental data, but the final experimental result is not affected, as can be seen from table 1 and table 2, the treatment effect of the experimental group four is significantly lower than that of the experimental group one, the experimental group two and the experimental group three, that is, the treatment effect of the anti-inflammatory and detumescent Chinese medicinal ointment for treating impetigo is totally greater than that of the erythromycin ointment in the embodiment 4, and the magnitude relationship of the treatment effects in the 3 embodiments of the anti-inflammatory and detumescent Chinese medicinal ointment for treating impetigo is as follows: the second ointment is larger than the first ointment and is larger than the third ointment, so that the components of the raw materials in the embodiment 2 are in the optimal proportion.
Therefore, the anti-inflammatory and detumescent traditional Chinese medicine ointment for treating impetigo comprises the following components in parts by weight: 4 parts of rosin, 1 part of yellow wax, 1 part of frankincense, 1 part of myrrh, 1 part of dragon's blood, 13 parts of fistular onion stalk, 10 parts of tung oil, 3 parts of garden burnet root and 5 parts of aloe, and the anti-inflammation and detumescence effect aiming at the sore is most obvious.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (8)
1. An anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo is characterized by comprising the following components in parts by weight:
0.2 to 27 parts of rosin, 0.1 to 16 parts of yellow wax, 0.2 to 15 parts of frankincense, 0.3 to 23 parts of myrrh, 0.4 to 19 parts of dragon's blood, 5 to 36 parts of fistular onion stalk, 4 to 34 parts of tung oil, 1 to 25 parts of garden burnet and 2 to 29 parts of aloe.
2. The anti-inflammatory and edema-removing traditional Chinese medicine ointment for treating impetigo according to claim 1, which comprises the following components in parts by weight: 0.5 to 21 parts of rosin, 0.1 to 13 parts of yellow wax, 0.2 to 12 parts of frankincense, 0.3 to 19 parts of myrrh, 0.4 to 16 parts of dragon's blood, 7 to 28 parts of fistular onion stalk, 5 to 31 parts of tung oil, 1 to 20 parts of garden burnet and 2 to 24 parts of aloe.
3. The anti-inflammatory and edema-removing traditional Chinese medicine ointment for treating impetigo according to claim 2, which comprises the following components in parts by weight: 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh, 0.4-12 parts of dragon's blood, 8-23 parts of fistular onion stalk, 7-25 parts of tung oil, 1-16 parts of garden burnet and 3-20 parts of aloe.
4. The preparation method of the anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo according to claim 3, which is characterized by comprising the following steps:
s1, washing and airing 8-23 parts of fistular onion stalk, slicing, juicing, and filtering to obtain fistular onion stalk juice;
s2, taking 1-18 parts of rosin, 0.3-11 parts of yellow wax, 0.5-9 parts of frankincense, 0.4-14 parts of myrrh and 0.4-12 parts of dragon' S blood, cleaning impurities, drying, grinding, and sieving with a 300-mesh sieve to obtain mixed medicinal powder;
s3, peeling 3-20 parts of aloe, putting the aloe into a container without water and oil, adding the mixed medicinal powder obtained in the step S2, and stirring to be thick to obtain an ointment;
s4, placing 7-25 parts of tung oil into a clean earthen pot, adding the fistular onion stalk juice obtained in the step S1 according to the mass ratio of 1:1.2-1.7, heating with soft fire for 0.3-0.5h, and cooling to obtain a mixed solution;
s5, mixing the mixed liquid in the step S4 and the ointment in the step S3 according to the mass ratio of 2:1.1-1.6, uniformly stirring, and disinfecting under an ultraviolet lamp to obtain the anti-inflammation and edema-removing traditional Chinese medicine ointment for treating the impetigo.
5. The method for preparing an anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo according to claim 4, wherein the filtering in the step S1 is specifically as follows: filtering with 400 mesh filter screen for 3 times.
6. The method for preparing an anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo according to claim 5, wherein the drying temperature in the step S2 is 75-100 ℃.
7. The method for preparing an anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo according to claim 6, wherein the stirring speed in the step S3 is 200-350 r/min.
8. The method for preparing an anti-inflammatory and anti-swelling traditional Chinese medicine ointment for treating impetigo according to claim 7, wherein the mixed solution and the ointment in the step S5 are mixed according to a mass ratio of 2: 1.2-1.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111453887.6A CN114053361A (en) | 2021-12-01 | 2021-12-01 | Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111453887.6A CN114053361A (en) | 2021-12-01 | 2021-12-01 | Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114053361A true CN114053361A (en) | 2022-02-18 |
Family
ID=80228201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111453887.6A Pending CN114053361A (en) | 2021-12-01 | 2021-12-01 | Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114053361A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406615A (en) * | 2001-09-10 | 2003-04-02 | 谢立芳 | Medicine against for beriberi and sore and boil |
| CN1698731A (en) * | 2005-05-25 | 2005-11-23 | 王�锋 | Externally applied medicine for treating skin ulcer |
| CN102274305A (en) * | 2011-08-04 | 2011-12-14 | 梁海胜 | Detoxifying ointment prepared from Chinese herbal medicines |
-
2021
- 2021-12-01 CN CN202111453887.6A patent/CN114053361A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406615A (en) * | 2001-09-10 | 2003-04-02 | 谢立芳 | Medicine against for beriberi and sore and boil |
| CN1698731A (en) * | 2005-05-25 | 2005-11-23 | 王�锋 | Externally applied medicine for treating skin ulcer |
| CN102274305A (en) * | 2011-08-04 | 2011-12-14 | 梁海胜 | Detoxifying ointment prepared from Chinese herbal medicines |
Non-Patent Citations (1)
| Title |
|---|
| 陈旭东: "赤小豆在兽医临床的妙用", 《中兽医学杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104288504B (en) | A kind of Chinese medicine ointment formulation for treating burn, scald and preparation method thereof | |
| CN101961404A (en) | Chinese medicinal paste for treating dermatosis and preparation method thereof | |
| CN108619362A (en) | A kind of acne cream and preparation method thereof | |
| CN101647891A (en) | Liquid medicine for treating burn and scald | |
| CN100425238C (en) | Medicine for treating burns | |
| CN101869636A (en) | Granulation-promoting paste with main components of sinkiang arnebia root and sesame oil | |
| CN114053361A (en) | Anti-inflammation and swelling-removing traditional Chinese medicine ointment for treating impetigo and preparation method thereof | |
| CN102078549A (en) | Traditional Chinese medicine for treating oxyuriasis | |
| CN104435383A (en) | Compound ointment for treating burns, scalds and skin traumatic ulcers and preparation method | |
| CN105250712B (en) | A kind of Chinese medicine composition for treating bedsore | |
| CN106806545A (en) | A kind of removing necrosis, promoting granulation herbal composite and preparation method thereof | |
| CN103330810B (en) | Emergency medicine for snake wounds | |
| CN105148065A (en) | Traditional Chinese medicine powder for treating scalds and preparation method | |
| CN102028771A (en) | Gromwell root and safflower ulcer ointment | |
| CN107569580B (en) | A topical Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
| CN108686080A (en) | A kind of band bed sore ointment and preparation method thereof | |
| CN114010704B (en) | External traditional Chinese medicine composition for treating pyocutaneous disease, medicated thread and preparation method | |
| CN101716191A (en) | Externally applied traditional Chinese medicine composition for treating bedsores | |
| CN102805785B (en) | Tai chi oil and preparation method thereof | |
| CN108295178B (en) | Traditional Chinese medicine composition and traditional Chinese medicine ointment for treating refractory wound and preparation method thereof | |
| CN114129671A (en) | Externally applied traditional Chinese medicine for clearing toxin and relieving swelling of eyes and preparation method thereof | |
| CN108261463A (en) | A kind of windproof Chinese medicine of folium artemisiae argyi controls cutaneous pruritus effervescent tablet | |
| CN105288083A (en) | Externally-applied medicine for treatment of boils and carbuncles and preparation method thereof | |
| CN105477015A (en) | External-use traditional Chinese medicine lotion for postoperative anal fistula and preparation method thereof | |
| CN1170555C (en) | Chinese patent medicine for treating ulcer diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220218 |